VALIANT LABORATORIES
Back to Balance Sheet
|
VALIANT LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Total Liabilities | ₹401 Cr | ₹343 Cr | ₹213 Cr |
What is the latest Total Liabilities ratio of VALIANT LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹401 Cr |
| Mar2024 | ₹343 Cr |
| Mar2023 | ₹213 Cr |
How is Total Liabilities of VALIANT LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹401 Cr | 16.97 | |
| Mar2024 | ₹343 Cr | 60.91 | |
| Mar2023 | ₹213 Cr | - | |
Compare Total Liabilities of peers of VALIANT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VALIANT LABORATORIES | ₹657.6 Cr | 6.3% | 45.8% | 47.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,278.0 Cr | -2.5% | -4.7% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹243,966.0 Cr | -4% | 8.1% | 55.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.3% | 0.2% | 36.6% | Stock Analytics | |
| CIPLA | ₹109,950.0 Cr | -1.7% | -6.1% | -12% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,967.4 Cr | -0.2% | -4.4% | -10.2% | Stock Analytics | |
VALIANT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VALIANT LABORATORIES | 6.3% |
45.8% |
47.5% |
| SENSEX | -2.8% |
-5.2% |
-8.4% |
You may also like the below Video Courses